About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Equity Capital Raising Placement of New Shares

September 1, 2014

Click here to read more

Post navigation

Financial Report for Half Year ended 30 June 2014

Phosphagenics Announces Successful Results from its Phase 2 TPM®/Tretinoin Gel Study on Acne Patients

Related Posts

Avecho’s Phase III Clinical Trial for Insomnia Commences

March 26, 2024March 26, 2024

Ethics Approval to Commence Topical TPM®/Oxycodone Patch Trial

December 8, 2014

Enrolment commences for Phase I human clinical trial

September 15, 2021September 15, 2021

Recent Posts

Euroz Hartleys | Successful Phase 3 Interim Results
July 8, 2026
Avecho Phase III insomnia trial advances following positive interim analysis
June 24, 2026
Euroz Hartleys Initiates Research Coverage
May 21, 2026

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.